A novel selective adenylyl cyclase 1 (AC1) inhibitor, IC50=2.3 µM . Inhibits calcium2+-stimulated cAMP accumulation in HEK cells stably transfected with AC11. It was also shown to inhibit AC1 stimulated by forskolin- and Galphas-coupled receptors in HEK-AC1 cells. It enhanced µ-opioid receptor-mediated inhibition of AC1 but it blocked heterologous sensitization of AC1 caused by chronic µ-opioid receptor activation.1 Displays analgesic properties in a mouse model of inflammatory pain.1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten